GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Medikaloka Hermina Tbk (ISX:HEAL) » Definitions » YoY EBITDA Growth

PT Medikaloka Hermina Tbk (ISX:HEAL) YoY EBITDA Growth : 54.28% (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is PT Medikaloka Hermina Tbk YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. PT Medikaloka Hermina Tbk's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 54.28%.

PT Medikaloka Hermina Tbk's EBITDA per Share for the three months ended in Jun. 2024 was Rp23.82.


PT Medikaloka Hermina Tbk YoY EBITDA Growth Historical Data

The historical data trend for PT Medikaloka Hermina Tbk's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Medikaloka Hermina Tbk YoY EBITDA Growth Chart

PT Medikaloka Hermina Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only 29.46 73.87 64.62 -56.29 35.48

PT Medikaloka Hermina Tbk Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.94 66.41 61.91 46.11 54.28

PT Medikaloka Hermina Tbk YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

PT Medikaloka Hermina Tbk's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(74.814-55.221)/ | 55.221 |
=35.48 %

PT Medikaloka Hermina Tbk's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(23.82-15.439)/ | 15.439 |
=54.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Medikaloka Hermina Tbk YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of PT Medikaloka Hermina Tbk's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Medikaloka Hermina Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Selangit B-10 Kavling No. 4, Hermina Tower, Kemayoran, Jakarta, IDN, 10610
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.

PT Medikaloka Hermina Tbk Headlines

No Headlines